fda compounding glp-1 enforcement news today 2025 National Hispanic Medical Association | The federal government is stepping up to stop counterfeit weight-loss drugs. In 2025, bipartisan lawmakers urged stronger Safe use of compounded GLP

The UK advertising regulator said monitoring weight loss drug ads by pharmacies and clinics remainsa priority.

PMCID: PMC10933338

AstraZeneca has recruited a new star to its budding GLP-1 show, picking up an early-stage oral candidate from Chinas Eccogene in a deal featuring $185 million upfront

Triple therapy combining an SGLT2 inhibitor, a GLP-1 receptor agonist and the thiazolidinedione pioglitazone could serve as an optimal solution for cardiovascular and renal protection in type 2 diabetes, according to a speaker.The impact of triple therapy on CV outcomes remains difficult to discern

Contact Noakes Law Group today for a free consultation